Neurology Conference 2026 – Florida, USA
🎯 Selling to this event's audience? Get a free tailored buyer list
Tell us your work email and our AI instantly builds a buyer list matched to Neurology Conference 2026 – Florida, USA — the best‑fit companies to target, the exact decision‑maker job titles, and the industry filters that fit what you sell.
🔒 Get my buyer details Free · ~20 seconds
About this event
Neurology Conference 2027 (Hybrid) – Neurology, Brain Health & Neurological Disorders
The 13th Edition of the International Conference on Neurology, Brain Health & Neurological Disorders is scheduled for June 24–26, 2027. The conference will take place in Rome, Italy and also be available as a hybrid event, allowing attendees to participate virtually from anywhere.
Event Theme
Centered around the theme "Connecting Minds: Innovations in Neurology and Patient Care", the conference is designed to bring together a multidisciplinary community focused on advancing neurological care through scientific exchange, clinical insights, and innovation.
Where It’s Held
Venue: NH Villa Carpegna
Address: Via Pio IV, 6, 00165 Roma RM, Italy
Who Attends (Multidisciplinary Neurology Community)
The program is presented as an open forum for thought leaders and emerging voices across neurology and related disciplines. The event brings together a multidisciplinary audience including:
- Academic neurologists
- Neuroscientific researchers
- Clinical practitioners
- Pharmaceutical innovators
- Policy advocates
Scientific Focus Areas
The agenda spans a broad range of scientific and clinical topics, emphasizing the integration of advanced diagnostics, therapeutic approaches, neurotechnology innovations, and patient-centered strategies. Key themes highlighted across the scientific sessions include:
- Alzheimer’s and Parkinson’s diseases
- Stroke diagnosis and management
- Neurodegenerative diseases
- Brain tumors and neuro-oncology
- Epilepsy and seizure disorders
- Artificial intelligence in neurology and neurosurgery
- Neuroimmunology and neurological infections
- Clinical neurology
- Neuropharmacology and novel drug development
- Cognitive and memory disorders
- Neurological interventions and surgery
- Pediatric neurology
- Neurological rehabilitation
- Advances in neuroimaging techniques
- Translational neurology
- Trauma and neurocritical care
Innovation & Emerging Directions
The conference also highlights emerging trends shaping the neurological sciences, including artificial intelligence, precision medicine, and neurorehabilitation. The goal is to support both theoretical exploration and evidence-based application for real-world patient impact.
Participation & Engagement
Attendees can contribute through opportunities to present original work and engage through expert dialogues and themed scientific sessions, including keynote discussions, case-based exchanges, and structured sessions across the core tracks. Networking opportunities are positioned to foster collaboration and innovation across specialties and sectors.
Official Outlook
With the hybrid format, Neurology 2027 is presented as a global meeting point for neurological discovery— supporting in-person participation in Rome, Italy and virtual attendance for those joining remotely.
Data sheet
Neurology Conference 2026 – Florida, USA – Event Attendee & Buyer Profile Analysis
Event Date: June 24–26, 2027 (official website content)
Location: Rome, Italy (official website content)
Event Status: Upcoming
Research Date: July 2, 2026
Event Overview
| Event Name | 13th Edition of International Conference on Neurology, Brain Health & Neurological Disorders (Neurology 2027) |
| Event Date | June 24–26, 2027 |
| Event Status | Upcoming |
| Venue | NH Villa Carpegna |
| City | Rome |
| State / Region | Lazio |
| Country | Italy |
| Organizer | Magnus Group / Magnus Conferences |
| Official Event Website | neurology.magnusconferences.com |
| Event Type | Hybrid scientific conference / medical conference / neurology meeting |
| Primary Category | Medical & Pharma |
| Secondary Applicable Categories | Science & Research, IT & Technology |
| Audience Reach | Global scientific and clinical audience, with in-person and virtual participation |
| Estimated Attendance / Expected Footfall | Attendance figure not publicly confirmed by the organizer. |
| Attendance Data Reliability | Low to Medium; official agenda and event description are confirmed, but no public attendance number was found in the supplied source content. |
| Main Purpose of Event | Scientific exchange on neurology, brain health, neurological disorders, clinical practice, research, diagnostics, treatment innovation, and professional networking. |
About the Event
Neurology 2027 is a hybrid international conference focused on neurology, brain health, and neurological disorders. The official website presents the meeting as a multidisciplinary forum for academic neurologists, neuroscientific researchers, clinical practitioners, pharmaceutical innovators, and policy advocates, with both in-person and virtual access.
The event is relevant for scientific collaboration, clinical education, innovation scouting, and research-led business development in the neurological care ecosystem. Its agenda includes neurodegenerative diseases, stroke, epilepsy, neuroimaging, neuropharmacology, pediatric neurology, neurocritical care, and artificial intelligence in neurology, making it valuable for suppliers and solution providers aligned with healthcare research, diagnostics, therapeutics, and digital health.
1. Who Attends: Buyers / Attendees
| Buyer / Attendee Segment | Typical Organizations | Buying Role or Influence | Relevance to Exhibitors / Suppliers |
|---|---|---|---|
| Academic neurologists and faculty clinicians | Universities, teaching hospitals, research institutes | Influence on clinical protocols, research adoption, and product evaluation | High for diagnostics, devices, software, and therapeutics |
| Hospital neurology department leaders | Hospitals, integrated delivery networks, specialty clinics | Operational and clinical decision-making | Relevant for imaging, monitoring, workflow, and care-management solutions |
| Neuroscientific researchers | Research labs, institutes, universities, biotech centers | Research tool selection and collaborative study influence | Strong fit for research instruments, lab services, data tools, AI platforms |
| Pharmaceutical and biotech medical affairs teams | Pharma, biotech, clinical research organizations | Evidence generation, KOL engagement, education sponsorship | High for drug development, trial solutions, and speaker partnerships |
| Clinical trial and translational research teams | CROs, hospitals, universities, life sciences firms | Protocol execution, site selection, recruitment strategy | Relevant for patient recruitment, data management, and research services |
| Neurosurgery and interventional specialists | Hospitals, surgical centers, specialty practices | Procedure and technology evaluation | Important for surgical tools, imaging, and neurotechnology vendors |
| Pharmacists and neuropharmacology specialists | Hospitals, pharma, research institutions | Therapeutic assessment and medication optimization | Relevant for drug information, therapeutic innovation, and education |
| Digital health and AI solution evaluators | Health tech firms, hospitals, research groups | Technology selection and pilot adoption | Strong relevance for AI, analytics, imaging, and remote-monitoring vendors |
| Policy advocates and association leaders | Associations, public health organizations, nonprofits | Standards, advocacy, and educational programming influence | Useful for sponsorship, partnerships, and education-oriented outreach |
| Medical device and diagnostics stakeholders | Device companies, imaging firms, lab diagnostics firms | Product positioning and clinician feedback | High for demonstration, KOL outreach, and channel development |
2. Event Location and Attendee Geographic Origin
| Geographic Area | Likely Attendee Origin | Buyer Concentration | Notes |
|---|---|---|---|
| Host city | Rome metro area | Medium | Venue-based attendance and local academic participation |
| Host region | Lazio and central Italy | Medium | Regional hospitals, universities, and healthcare professionals |
| Nearby business hubs | Milan, Florence, Naples, Bologna, Turin | Medium | Italy-wide professional travel is plausible for clinical and academic attendees |
| National reach | Italy | High | Scientific conference topic supports national participation |
| International reach | Europe, Middle East, Asia, North America, global research community | High | Official website states hybrid access and global connectivity |
| Trade corridor relevance | Cross-border medical research and healthcare innovation networks | Medium | Suitable for international outreach and research collaboration targeting |
3. Audience Reach
| Reach Level | Assessment | Explanation |
|---|---|---|
| Global | Primary classification | The official website describes a hybrid conference intended for a worldwide audience, with participation from clinicians, researchers, and industry stakeholders across geographies. |
4. Sample Buyer Companies and Websites
| Buyer Company / Organization | Buyer Type | Why It Is Relevant | Website | Best Job Titles to Target | Evidence Level |
|---|---|---|---|---|---|
| Mayo Clinic | Health system / research hospital | Large neurology and neuroscience footprint; strong fit for clinical, research, and education engagement | mayoclinic.org | Neurology Chair, Director of Research, Clinical Operations Director | Strong Market Fit, Attendance Not Confirmed |
| Cleveland Clinic | Health system / specialty hospital | Major neurology and neurosurgery buyer and clinical influencer | clevelandclinic.org | Neurology Director, Neurosurgery Director, Innovation Manager | Strong Market Fit, Attendance Not Confirmed |
| Mass General Brigham | Health system / academic medical center network | Relevant for neurology, research translation, and clinical adoption | massgeneralbrigham.org | Department Chair, Research Director, Clinical Program Manager | Strong Market Fit, Attendance Not Confirmed |
| Johns Hopkins Medicine | Academic medical center | High-value neuroscience, research, and clinical decision-maker organization | hopkinsmedicine.org | Neurology Chair, Research Director, Innovation Lead | Strong Market Fit, Attendance Not Confirmed |
| UCSF Health | Academic health system | Strong neurology and neuroscience research and clinical influence | ucsfhealth.org | Director of Neurology, Research Manager, Clinical Trials Lead | Strong Market Fit, Attendance Not Confirmed |
| Mount Sinai Health System | Health system / research hospital | Large neurology department and translational research interest | mountsinai.org | Department Chair, Innovation Officer, Clinical Research Director | Strong Market Fit, Attendance Not Confirmed |
| Imperial College Healthcare NHS Trust | Public healthcare provider | International neurology stakeholder and clinical education buyer | imperial.nhs.uk | Clinical Director, Service Line Lead, Research Lead | Strong Market Fit, Attendance Not Confirmed |
| King's College Hospital NHS Foundation Trust | Public healthcare provider | Neurology and stroke-care relevant organization with decision-making roles | kch.nhs.uk | Clinical Lead, Research Manager, Service Director | Strong Market Fit, Attendance Not Confirmed |
| Novartis | Pharmaceutical company | Neurology drug development, medical affairs, and speaker engagement relevance | novartis.com | Medical Affairs Director, CNS Brand Lead, Clinical Development Director | Strong Market Fit, Attendance Not Confirmed |
| Roche | Pharmaceutical / diagnostics company | Relevant for diagnostics, biomarkers, and neuroscience R&D engagement | roche.com | Medical Affairs, Diagnostics Partnerships Lead, R&D Director | Strong Market Fit, Attendance Not Confirmed |
| Eli Lilly and Company | Pharmaceutical company | Neurology and neuroscience pipeline relevance; strong medical affairs fit | lilly.com | Medical Director, Clinical Development, Strategic Partnerships | Strong Market Fit, Attendance Not Confirmed |
| Medtronic | Medical device company | Neurotechnology, neuromodulation, and surgical solutions relevance | medtronic.com | Product Manager, Clinical Affairs, Business Development Director | Strong Market Fit, Attendance Not Confirmed |
| GE HealthCare | Medical imaging / diagnostics company | MRI, CT, and neuroimaging relevance for neurology professionals | gehealthcare.com | Imaging Sales Director, Product Marketing Manager, Clinical Applications Manager | Strong Market Fit, Attendance Not Confirmed |
5. Job Profiles, Industries and Event Type
| Priority | Job Title / Function | Department | Seniority Level | Why This Role Matters |
|---|---|---|---|---|
| 1 | Chair of Neurology / Neurology Director | Clinical | Director / VP | Key clinical decision-maker for therapies, tools, and educational partnerships |
| 2 | Neuroscience Research Director | Research | Director / Senior Director | Strong for research tools, grants, collaborations, and study-enablement solutions |
| 3 | Principal Investigator / Professor of Neurology | Academic / Research | Senior / Lead | Influences evidence generation, publications, and product validation |
| 4 | Clinical Trials Director | Clinical Research | Director / Manager | Relevant for trial operations, recruitment, and data management vendors |
| 5 | Medical Affairs Director | Pharma / Biotech | Director / VP | Can sponsor, partner, and engage KOLs at the conference |
| 6 | Clinical Program Manager | Operations / Clinical | Manager / Director | Useful for workflow, care pathway, and implementation vendors |
| 7 | Product Manager, Neurotech / Diagnostics | Product | Manager / Senior Manager | Evaluates market needs and product positioning |
| 8 | Clinical Applications Manager | Customer Success / Clinical Support | Manager | Important for device, imaging, and software adoption support |
| 9 | R&D Director | Research & Development | Director / VP | Relevant for innovation partners and technology suppliers |
| 10 | Research Coordinator / Study Manager | Clinical Research | Coordinator / Manager | Influences trial operations, vendor selection, and event follow-up |
| Priority | Apollo Industry | Why It Fits the Event | Best Buyer Use Case |
|---|---|---|---|
| 1 | Hospital & Health Care | Primary buyer universe for neurology, stroke, neurosurgery, and clinical adoption | Hospitals, clinics, academic health systems |
| 2 | Research | Scientific and translational research focus | Labs, institutes, research centers |
| 3 | Pharmaceuticals | Drug development, medical affairs, and neurology therapeutics | CNS pipeline, education, partnerships |
| 4 | Biotechnology | Neurology-focused biotech innovation and trial activity | Biomarkers, novel therapies, clinical studies |
| 5 | Medical Devices | Neuro devices, imaging, monitoring, and surgical tools | Device sales, product demos, clinical validation |
| 6 | Medical Practice | Private neurology and specialist practices attend for education and tools | Practice management, diagnostics, patient care |
| 7 | Information Technology & Services | Digital health, AI, analytics, telehealth, and data platforms | Software, analytics, interoperability |
| 8 | Biotechnology Research | Specialist scientific buyer segment | Translational studies, lab services |
| 9 | Health, Wellness & Fitness | Broader patient outcome and care-pathway interest | Rehab, patient support, wellness |
| 10 | Government Administration | Public health and policy stakeholders may participate | Health policy, public systems, grants |
| 11 | Computer Software | AI and analytics platforms used in neurology | Clinical AI, imaging software, data platforms |
6. Estimated Attendance
| Metric | Figure | Status | Source / Basis | Notes |
|---|---|---|---|---|
| Estimated total footfall | Not publicly confirmed | Unconfirmed | Official website content supplied; no public attendee count provided | Use list-building assumptions cautiously |
| Exhibitor count | Not publicly confirmed | Unconfirmed | No exhibitor directory in supplied content | Event appears primarily scientific rather than trade-floor driven |
| Buyer count | Not publicly confirmed | Unconfirmed | No official buyer list provided | Buyer profiling should be role-based rather than list-based |
| Speaker count | Not publicly confirmed in supplied content | Unconfirmed | Official website mentions speakers but no count in provided text | Speaker list may improve outreach targeting if available later |
| Sponsor count | Not publicly confirmed | Unconfirmed | No sponsor roster in supplied content | Not enough data for sponsor-based prospecting |
| Historical attendance | Not available from supplied source text | Unavailable | Official site references past editions but no attendance figures were included | Attendance figure not publicly confirmed by the organizer. |
7. Key Focus Areas and Buyer Engagement
| Focus Area | Typical Buyer Need | Buyer Engagement Opportunity | Relevant Supplier Offering |
|---|---|---|---|
| Clinical neurology | Better patient outcomes and clinical workflow | Education, demos, case studies, KOL engagement | Clinical solutions, care pathways, support services |
| Diagnostics and neuroimaging | Accurate detection and faster diagnosis | Product demonstrations and clinical validation discussions | MRI, CT, software, image analysis, biomarkers |
| Neurodegenerative disease | Treatment pathways and research progress | Pharma outreach, trial engagement, evidence sharing | Therapeutics, clinical trial services, data platforms |
| Stroke and neurocritical care | Emergency response, acute care, recovery tools | Hospital procurement and department-level outreach | Monitoring, workflow, rehabilitation, device support |
| AI in neurology | Decision support and automation | Technology buyer meetings and innovation sessions | AI software, analytics, workflow automation, triage tools |
| Neuropharmacology | Therapeutic innovation and evidence review | Pharma partnerships, drug-development networking | Therapeutics, lab services, med affairs support |
| Neurorehabilitation | Post-acute recovery and patient support | Engage rehab leaders and care pathway owners | Rehab devices, digital therapy, remote monitoring |
Lead Quality Assessment
| Factor | Assessment | Explanation |
|---|---|---|
| Buyer relevance | Very High | Strong concentration of clinicians, researchers, pharma, and medtech stakeholders. |
| Decision-maker availability | High | Likely presence of department heads, directors, researchers, and medical affairs leaders. |
| Data collection potential | Medium | Agenda and speaker data help targeting, but no public attendee list was supplied. |
| Apollo targeting potential | High | Clear fit for hospital, pharma, biotech, medtech, and research filters. |
| Geographic targeting potential | High | Hybrid format supports Europe-wide and global outreach. |
| Best outreach approach | Educational + partnership-led | Use scientific relevance, clinical value, and research collaboration as primary hooks. |
| Overall lead quality | High | Excellent for healthcare, pharma, medtech, and research prospecting. |
| Best use case | B2B attendee list building and targeted outreach | Well suited for speaker, sponsor, exhibitor, and attendee prospecting. |
| Limitations / risks | No current-year attendee list confirmed | Prospecting should rely on role fit, agenda fit, and prior-year evidence where available. |
Apollo.io Targeting Recommendation
| Filter Type | Recommended Filters | Purpose |
|---|---|---|
| Apollo industries | Hospital & Health Care; Pharmaceuticals; Biotechnology; Medical Devices; Research; Information Technology & Services | Core event audience match |
| Departments | Clinical; Research; Medical Affairs; Product; Innovation; Operations; Procurement; IT | Target decision-makers and influencers |
| Seniority | Manager; Director; VP; CXO; Partner; Professor; Head | Prioritize authority and budget influence |
| Job titles | Neurology Director; Medical Affairs Director; Research Director; Clinical Trials Director; Product Manager; Clinical Applications Manager; R&D Director; CIO; CTO | Role-based event lead capture |
| Geography | Italy; Western Europe; EU; UK; North America; Middle East; Global | Match the hybrid international audience |
| Employee size | 51–200; 201–500; 501–1,000; 1,001–5,000; 5,001+ | Covers hospitals, pharma, biotech, and medtech buyers |
| Keywords | neurology OR neuroscience OR stroke OR epilepsy OR neuroimaging OR neuropharmacology OR neurorehabilitation OR CNS OR brain health | Focus search on event themes |
| Technologies | AI, imaging, analytics, telehealth, clinical research software, medical device software | Useful for digital health and medtech vendor targeting |
| Company type | Hospitals; academic medical centers; pharma; biotech; medical device; CROs; research institutes | Prioritize qualified buyer organizations |
Suggested Apollo Search Logic: (neurology OR neuroscience OR stroke OR epilepsy OR CNS OR brain health) AND (hospital OR research OR pharmaceutical OR biotechnology OR medical device OR clinical trials) AND (Director OR VP OR Head OR Manager OR Professor). Use geography filters for Italy, EU, UK, North America, and global medical centers.
Client Fit Review Required
Please share the client website or product/service details. I will review the client offering and identify the highest-fit buyer companies, Apollo industries, seniority levels, departments, and job titles from this event.
Sources & Verification Notes
| Source | Type | What It Verified | Reliability |
|---|---|---|---|
| Magnus Conferences – Neurology official event website | Official organizer website | Event title, hybrid format, dates, venue, city, country, theme, and scientific sessions | High |
| Supplied official website content excerpt | Primary source text | Confirmed June 24–26, 2027 in Rome, Italy and the hybrid conference description | High |
🎯 Selling to this event's audience? Get a free tailored buyer list
Tell us your work email and our AI instantly builds a buyer list matched to Neurology Conference 2026 – Florida, USA — the best‑fit companies to target, the exact decision‑maker job titles, and the industry filters that fit what you sell.
🔒 Get my buyer details Free · ~20 seconds